FDA Import Refusal 1FX-3848193-4/20002/1B — Revance Therapeutics, Inc
The FDA refused shipment 1FX-3848193-4/20002/1B from Revance Therapeutics, Inc (United States) on Sep 25, 2026. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charges: 118,3280,75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Sep 25, 2026
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 58PDZ05 ONABOTULINUMTOXINA
- Charges
- 118,3280,75